Zenlabs Ethica Limited
ZENLABS.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$176.1M
Close$
$-12.58
146.5% downside
Current Fair Value
146.5% downsideOvervalued by 146.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $176.10 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.97 |
| Beta | 0.17 |
| Outstanding Shares | 6,490,909 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -6.94 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zenlabs Ethica Limited
65 employees
CEO: Vinod Kumar Zenlabs Ethica Limited operates as a pharmaceutical firm specializing in the commerce of medicinal goods. Its extensive product range covers numerous therapeutic categories, including but not limited to pain management and anti-inflammat...